

CLASSIFICATION: METABOLIC MODULATOR
ACTIVE SUBSTANCE: SLU-PP-332
FORM: 100 TABLETS x 1000 MCG
ACTIVE HALF-LIFE: ~ 6–8 HOURS
DOSAGE: 1000–2000 MCG/DAY (SPLIT INTO 2 DOSES)
ACNE: NO
WATER RETENTION: NONE
HBR: UNLIKELY
HEPATOTOXICITY: NONE REPORTED
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
SLU-PP-332 by Dragon Pharma is an experimental metabolic enhancer designed to target fat loss and energy regulation. Each bottle contains 100 tablets dosed at 1000 mcg per tab, delivering a highly concentrated form of this innovative compound. While still under investigation, SLU-PP-332 has gained interest among research communities and performance-focused users for its potential impact on mitochondrial activity and metabolic rate enhancement.
SLU-PP-332 is a novel metabolic compound believed to activate the PPAR-delta pathway (Peroxisome proliferator-activated receptor delta), which plays a crucial role in regulating fatty acid metabolism, energy expenditure, and glucose utilization. Although not approved for medical use, it's being studied for its potential in fat burning, endurance improvement, and muscle preservation under calorie-restricted conditions.
As SLU-PP-332 is still under research, dosing protocols vary. Users commonly report a daily intake of 1000 mcg to 2000 mcg per day, split into one or two doses. A typical experimental cycle may range from 4 to 8 weeks, depending on tolerance and goals.
There is limited data on SLU-PP-332's long-term safety profile. Reported side effects are minimal, but may include transient fatigue or appetite suppression. Users are advised to avoid use if pregnant, nursing, or dealing with existing medical conditions without prior consultation with a healthcare provider.
Important Note: SLU-PP-332 is sold strictly for research purposes and is not intended for human consumption. Use responsibly and only as directed within a research setting.
Dragon Pharma is known for its strict quality control, consistent potency, and transparent third-party testing practices. Every batch of SLU-PP-332 is produced under GMP-compliant conditions, ensuring reliable results and trusted formulation. Explore more from the Dragon Pharma products lineup for cutting-edge performance and research tools.
Keep the container tightly sealed and stored in a cool, dry place away from direct sunlight and heat sources. Keep out of reach of children.
SLU-PP-332 is a selective PPARδ agonist, designed to mimic exercise-like metabolic benefits. It enhances fat burning, improves endurance, and boosts mitochondrial function in skeletal muscle.
Early research indicates good tolerability with minimal reported side effects. However, SLU-PP-332 is still under investigation and should be used responsibly, ideally under expert guidance.
Most users take between 1000–2000 mcg per day, often split into a morning and pre-training dose. Duration typically lasts 4 to 8 weeks, depending on fitness goals.
No, SLU-PP-332 does not suppress natural testosterone production and therefore does not require a PCT protocol like anabolic steroids or SARMs.
Please log in to write SLU-PP-332 review.
CLASSIFICATION: BETA-2 AGONIST, BRONCHODILATOR
ACTIVE SUBSTANCE: CLENBUTEROL HYDROCHLORIDE
FORM: 100 PILLS x 40 MCG
ACTIVE HALF-LIFE: 48-72 HOURS
DOSAGE: MEN 40-160 MCG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASS: BETA-2 AGONIST, BRONCHODILATOR
ACTIVE SUBSTANCES:
- 30 MCG CLENBUTEROL HYDROCHLORIDE
- 5.6 MG YOHIMBINE HYDROCHLORIDE
MIXED FORM: 10 ML VIAL x 5.8 MG
ACTIVE HALF-LIFE: 48-72 HOURS
DOSAGE: MEN 3.4-12.16 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS